Bold
Investors
ASX
Latest News
ASX Announcements
Companies
Home
ASX Announcements
CUV Announcements
CLINUVEL publicly files 20-F to U.S. SEC
CUV
CLINUVEL PHARMACEUTICALS LIMITED
Market sensitive
CLINUVEL publicly files 20-F to U.S. SEC
Date and time
16 June 2026 at 7:06 pm
Announcement type
Company Administration
Show details
Hide details
Category
Other
Report codes
12008
Sector
Health Care
Industry group
Pharmaceuticals, Biotechnology & Life Sciences
View on ASX
Open original PDF
CUV announcement history
Recent CUV announcements
CLINUVEL Annual Results - Investor Webinar
Becoming a substantial holder
CLINUVEL's injectable peptide platform
Commercial update on vitiligo
Update - SCENESSE in vitiligo
Notification of cessation of securities - CUV